- Home
- NNDM vs RCKT Comparison
NNDM vs RCKT Comparison
Compare NNDM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNDM
- RCKT
- Stock Information
- Founded
- NNDM 2012
- RCKT 1999
- Country
- NNDM United States
- RCKT United States
- Employees
- NNDM N/A
- RCKT N/A
- Industry
- NNDM Electrical Products
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- NNDM Technology
- RCKT Health Care
- Exchange
- NNDM Nasdaq
- RCKT Nasdaq
- Market Cap
- NNDM 334.6M
- RCKT 328.6M
- IPO Year
- NNDM N/A
- RCKT N/A
- Fundamental
- Price
- NNDM $1.40
- RCKT $3.28
- Analyst Decision
- NNDM
- RCKT Buy
- Analyst Count
- NNDM 0
- RCKT 13
- Target Price
- NNDM N/A
- RCKT $12.96
- AVG Volume (30 Days)
- NNDM 1.4M
- RCKT 6.0M
- Earning Date
- NNDM 09-09-2025
- RCKT 08-07-2025
- Dividend Yield
- NNDM N/A
- RCKT N/A
- EPS Growth
- NNDM N/A
- RCKT N/A
- EPS
- NNDM N/A
- RCKT N/A
- Revenue
- NNDM $58,812,000.00
- RCKT N/A
- Revenue This Year
- NNDM N/A
- RCKT N/A
- Revenue Next Year
- NNDM N/A
- RCKT $108.43
- P/E Ratio
- NNDM N/A
- RCKT N/A
- Revenue Growth
- NNDM 7.49
- RCKT N/A
- 52 Week Low
- NNDM $1.31
- RCKT $2.19
- 52 Week High
- NNDM $2.74
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- NNDM 50.50
- RCKT 51.17
- Support Level
- NNDM $1.39
- RCKT $2.88
- Resistance Level
- NNDM $1.45
- RCKT $3.74
- Average True Range (ATR)
- NNDM 0.05
- RCKT 0.27
- MACD
- NNDM 0.01
- RCKT 0.02
- Stochastic Oscillator
- NNDM 69.12
- RCKT 35.43
About NNDM Nano Dimension Ltd.
Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.